专题报道 |
|
|
|
|
山东省济宁地区新生儿脂肪酸氧化代谢病筛查及随访分析 |
杨池菊1( ),史彩虹2,周成1,万秋花1,周艳彬1,陈西贵1,靳宪莲1,黄成刚3,徐鹏1,*( ) |
1.济宁市妇幼保健计划生育服务中心新生儿疾病筛查中心,山东 济宁 272000 2.济宁市第二人民医院检验科,山东 济宁 272000 3.浙江博圣生物技术股份有限公司,浙江 杭州 310012 |
|
Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province |
YANG Chiju1( ),SHI Caihong2,ZHOU Cheng1,WAN Qiuhua1,ZHOU Yanbin1,CHEN Xigui1,JIN Xianlian1,HUANG Chenggang3,XU Peng1,*( ) |
1. Neonatal Disease Screening Center, Jining Maternal and Child Health and Family Planning Service Center, Jining 272000, Shandong Province, China; 2. Clinical Laboratory, Jining Second People’s Hospital, Jining 272000, Shandong Province, China; 3. Zhejiang Bosheng Biotechnology Co., Ltd., Hangzhou 310012, China |
引用本文:
杨池菊,史彩虹,周成,万秋花,周艳彬,陈西贵,靳宪莲,黄成刚,徐鹏. 山东省济宁地区新生儿脂肪酸氧化代谢病筛查及随访分析[J]. 浙江大学学报(医学版), 2021, 50(4): 472-480.
YANG Chiju,SHI Caihong,ZHOU Cheng,WAN Qiuhua,ZHOU Yanbin,CHEN Xigui,JIN Xianlian,HUANG Chenggang,XU Peng. Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province. J Zhejiang Univ (Med Sci), 2021, 50(4): 472-480.
链接本文:
http://www.zjujournals.com/med/CN/10.3724/zdxbyxb-2021-0259
或
http://www.zjujournals.com/med/CN/Y2021/V50/I4/472
|
1 |
MCHUGHD M S, CAMERONC A, ABDENURJ E, et al.Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project[J]Genet Med, 2011, 13( 3): 230-254.
doi: 10.1097/GIM.0b013e31820d5e67
|
2 |
马志军, 韩连书, 李水军, 等. MS/MS技术在新生儿氨基酸、有机酸及脂肪酸氧化代谢障碍性疾病筛查中的应用共识[J]. 检验医学,2019, 34(6): 479-485 MA Zhijun, HAN Lianshu, LI Shuijun, et al. Expert consensus on neonatal disease screening of amino acid, organic acid and fatty acid oxidative metabolic disorders using MS/MS technology[J]. Laboratory Medicine, 2019, 34(6): 479-485. (in Chinese)
|
3 |
RICHARDSS, AZIZN, BALES, et al.Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]Genet Med, 2015, 17( 5): 405-424.
doi: 10.1038/gim.2015.30
|
4 |
FRAZIERD M, MILLINGTOND S, MCCANDLESSS E, et al.The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005[J]J Inherit Metab Dis, 2006, 29( 1): 76-85.
doi: 10.1007/s10545-006-0228-9
|
5 |
WILCKENB, WILEYV, HAMMONDJ, et al.Screening newborns for inborn errors of metabolism by tandem mass spectrometry[J]N Engl J Med, 2003, 348( 23): 2304-2312.
doi: 10.1056/NEJMoa025225
|
6 |
FEUCHTBAUML, CARTERJ, DOWRAYS, et al.Birth prevalence of disorders detectable through newborn screening by race/ethnicity[J]Genet Med, 2012, 14( 11): 937-945.
doi: 10.1038/gim.2012.76
|
7 |
LINDNERM, GRAMERG, HAEGEG, et al.Efficacy and outcome of expanded newborn screening for metabolic diseases - report of 10 years from South-West Germany[J]Orphanet J Rare Dis, 2011, 6( 1): 44.
doi: 10.1186/1750-1172-6-44
|
8 |
LA MARCAG, MALVAGIAS, CASETTAB, et al.Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: update on methods to reduce false tests[J]J Inherit Metab Dis, 2008, 31( S2): 395-404.
doi: 10.1007/s10545-008-0965-z
|
9 |
LIMJ S, TANE S, JOHNC M, et al.Inborn error of metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): an 8 year journey from pilot to current program[J]Mol Genet Metab, 2014, 113( 1-2): 53-61.
doi: 10.1016/j.ymgme.2014.07.018
|
10 |
VILARINHOL, ROCHAH, SOUSAC, et al.Four years of expanded newborn screening in Portugal with tandem mass spectrometry[J]J Inherit Metab Dis, 2010, 33( S3): 133-138.
doi: 10.1007/s10545-010-9048-z
|
11 |
NAGARAJAD, MAMATHAS N, DET, et al.Screening for inborn errors of metabolism using automated electrospray tandem mass spectrometry: Study in high-risk Indian population[J]Clin Biochem, 2010, 43( 6): 581-588.
doi: 10.1016/j.clinbiochem.2009.12.009
|
12 |
CHACED H, DIPERNAJ C, NAYLORE W. Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millennium[J]Acta Paediatrica, 1999, 88( 432): 45-47.
doi: 10.1111/j.1651-2227.1999.tb01156.x
|
13 |
SCHULZEA, LINDNERM, KOHLMüLLERD, et al.Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications[J]Pediatrics, 2003, 111( 6): 1399-1406.
doi: 10.1542/peds.111.6.1399
|
14 |
SHIBATAN, HASEGAWAY, YAMADAK, et al.Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: selective screening vs. expanded newborn screening[J]Mol Genet Metab Rep, 2018, 5-10.
doi: 10.1016/j.ymgmr.2018.05.003
|
15 |
HANL, HANF, YEJ, et al.Spectrum analysis of common inherited metabolic diseases in Chinese patients screened and diagnosed by tandem mass spectrometry[J]J Clin Lab Anal, 2015, 29( 2): 162-168..
doi: 10.1002/jcla.21745
|
16 |
郑静, 张玉, 洪芳, 等. 浙江省新生儿脂肪酸氧化代谢疾病筛查及随访分析[J]. 浙江大学学报(医学版), 2017, 46(3): 248-255 ZHENG Jing, ZHANG Yu, HONG Fang, et al. Screening for fatty acid oxidation disorders of newborns in Zhejiang province: prevalence, outcome and follow-up[J]. Journal of Zhejiang University (Medical Sciences), 2017, 46(3): 248-255. (in Chinese)
|
17 |
MAGOULASP L, EL-HATTABA W. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management[J]Orphanet J Rare Dis, 2012, 7( 1): 68.
doi: 10.1186/1750-1172-7-68
|
18 |
LEEN C, TANGN L S, CHIENY H, et al.Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening[J]Mol Genet Metab, 2010, 100( 1): 46-50.
doi: 10.1016/j.ymgme.2009.12.015
|
19 |
LIF Y, EL-HATTABA W, BAWLEE V, et al.Molecular spectrum of SLC22A5 (OCTN2) gene mutations detected in 143 subjects evaluated for systemic carnitine deficiency[J/OL]Hum Mutat, 2010, 31( 8): E1632-E1651.
doi: 10.1002/humu.21311
|
20 |
TANGN L S, HWUW L, CHANR T, et al.A founder mutation (R254X) of SLC22A5 (OCTN2) in Chinese primary carnitine deficiency patients[J]Hum Mutat, 2002, 20( 3): 232..
doi: 10.1002/humu.9053
|
21 |
崔 冬, 胡宇慧, 唐 根, 等. 原发性肉碱缺乏症临床和基因突变特点及1例产前诊断研究[J]. 临床儿科学杂志, 2019, 37(6): 449-453 CUI Dong, HU Yuhui, TANG Gen, et al. Clinical and gene mutation characteristics of primary carnitine deficiency and prenatal diagnosis in one case[J].Journal of Clinical Pediatrics, 2019, 37(6): 449-453. (in Chinese)
|
22 |
王舒婷. 脂肪酸氧化障碍筛查与致病基因突变探讨[D]. 天津: 天津医科大学, 2020 WANG Shuting. Screening and pathogenic genes analysis of fatty acid oxidation deficiencies[D]. Tianjin: Tianjin Medical University, 2020. (in Chinese)
|
23 |
ADAM M P, ARDINGER H H, PAGON R A, et al. GeneReviews?[M/OL]//EL-HATTAB A W. Systemic primary carnitine deficiency. Seattle (WA): University of Washington, 1993-2019[2020-08-01]. https://www.ncbi.nlm.nih.gov/books/NBK84551/
|
24 |
CHIEN Y H, LEE N C, CHAO M C, et al. Fatty acid oxidation disorders in a Chinese population in taiwan [J]. JIMD Rep, 2013, 11: 165-172
|
25 |
ANS J, KIMS Z, KIMG H, et al.Compound heterozygous mutations of ACADS gene in newborn with short chain acyl-CoA dehydrogenase deficiency: case report and literatures review[J]Korean J Pediatr, 2016, 59( Suppl 1): S45-S48.
doi: 10.3345/kjp.2016.59.11.S45
|
26 |
MINKLERP E, STOLLM S K, INGALLSS T, et al.Quantitative acylcarnitine determination by UHPLC-MS/MS — going beyond tandem MS acylcarnitine “profiles”[J]Mol Genet Metab, 2015, 116( 4): 231-241.
doi: 10.1016/j.ymgme.2015.10.002
|
27 |
KOIZUMIA, NOZAKIJ, OHURAT, et al.Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency[J]Hum Mol Genet, 1999, 8( 12): 2247-2254.
doi: 10.1093/hmg/8.12.2247
|
28 |
VAN MALDEGEMB T, WANDERSR J A, WIJBURGF A. Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency[J]J Inherit Metab Dis, 2010, 33( 5): 507-511.
doi: 10.1007/s10545-010-9080-z
|
29 |
TONINR, CACIOTTIA, FUNGHINIS, et al.Clinical relevance of short-chain acyl-CoA dehydrogenase (SCAD) deficiency: exploring the role of new variants including the first SCAD-disease-causing allele carrying a synonymous mutation[J]BBA Clin, 2016, 114-119.
doi: 10.1016/j.bbacli.2016.03.004
|
30 |
PEDERSENC B, ZOLKIPLIZ, VANGS, et al.Antioxidant dysfunction: potential risk for neurotoxicity in ethylmalonic aciduria[J]J Inherit Metab Dis, 2010, 33( 3): 211-222.
doi: 10.1007/s10545-010-9086-6
|
31 |
王伟青, 李文杰, 宋东坡, 等. 短链酰基辅酶A脱氢酶缺乏症患儿临床特点及基因变异分析[J]. 临床儿科杂志, 2020, 38(9): 687-690 WANG Weiqing, LI Wenjie, SONG Dongpo, et al. Clinical characteristics and gene variation of short-chain acyl-CoA dehydrogenase deficiency[J]. Journal of Clinical Pediatrics, 2020, 38(9): 687-690. (in Chinese)
|
32 |
PENAL, ANGLEB, BURTONB, et al.Follow-up of patients with short-chain acyl-CoA dehydrogenase and isobutyryl-CoA dehydrogenase deficiencies identified through newborn screening: one center’s experience[J]Genet Med, 2012, 14( 3): 342-347.
doi: 10.1038/gim.2011.9
|
33 |
OBAID A, NASHABAT M, ALFADHEL M, et al. Clinical, iochemical, and molecular features in 37 Saudi patients with very long chain acyl CoA dehydrogenase deficiency [J]. JIMD Rep, 2018, 40: 47-53
|
34 |
SYKUT-CEGIELSKAJ, GRADOWSKAW, PIEKUTOWSKA-ABRAMCZUKD, et al.Urgent metabolic service improves survival in long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency detected by symptomatic identification and pilot newborn screening[J]J Inherit Metab Dis, 2011, 34( 1): 185-195.
doi: 10.1007/s10545-010-9244-x
|
35 |
PENAL D M, VAN CALCARS C, HANSENJ, et al.Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database[J]Mol Genet Metab, 2016, 118( 4): 272-281.
doi: 10.1016/j.ymgme.2016.05.007
|
36 |
SPIEKERKOETTERU, LINDNERM, SANTERR, et al.Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from aworkshop[J]J Inherit Metab Dis, 2009, 32( 4): 488-497.
doi: 10.1007/s10545-009-1125-9
|
37 |
BOUTRONA, ACQUAVIVAC, VIANEY-SABANC, et al.Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency[J]Mol Genet Metab, 2011, 103( 4): 341-348.
doi: 10.1016/j.ymgme.2011.04.006
|
38 |
ROCHA H, CAST?IRAS D, DELGADO C, et al. Birth prevalence of fatty acid beta-oxidation disorders in Iberia [J].JIMD Rep, 2014, 16: 89-94
|
39 |
LOUKASY L, SOUMELASG S, DOTSIKASY, et al.Expanded newborn screening in Greece: 30 months of experience[J]J Inherit Metab Dis, 2010, 33( S3): 341-348.
doi: 10.1007/s10545-010-9181-8
|
40 |
OERTONJ, KHALIDJ M, BESLEYG, et al.Newborn screening for medium chain acyl-CoA dehydrogenase deficiency in England: prevalence, predictive value and test validity based on 1.5 million screened babies[J]J Med Screen, 2011, 18( 4): 173-181.
doi: 10.1258/jms.2011.011086
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|